How to prevent the trocar-site hernia? A totally atraumatic endoscopic mini-IPOM-Plug technique (with extra-lightweight titanium coated mesh and glue)

ISRCTN ISRCTN67377966
DOI https://doi.org/10.1186/ISRCTN67377966
Secondary identifying numbers N/A
Submission date
16/11/2015
Registration date
01/12/2015
Last edited
16/11/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Laparoscopy is a type of surgery that allows a surgeon to access the inside of the body without having to make large incisions in the skin. The arrival of laparoscopy could be regarded as the biggest change in surgical techniques this century. However, there is a negative side to this new approach, such as a new kind of hernia, the trocar-site hernia. A hernia is a weakness or split in the muscle wall of the abdomen which allows the abdominal contents (usually some part of the intestine) to bulge out. With the increasing use of laparoscopic surgery the problem of this new type of hernia will increase too. The surgical placement of a prophylactic (preventive) mesh may help to prevent trocar-site hernia. The aim of this study is to find out whether it is possible to prevent trocar-site hernia after laparoscopic cholecystectomy by placing a prophylactic mesh.

Who can participate?
Patients aged 20-70 undergoing laparoscopic cholecystectomy (gallbladder removal) for cholelitiasis (gallstones).

What does the study involve?
Patients are randomly allocated to either receive a prophylactic mesh or to not receive a mesh during their operation.

What are the possible benefits and risks of participating?
The patients who receive the mesh may be at risk of seroma (collection of fluid) or wound infection at the mesh site. The patients who do not receive the mesh may be at risk of hernia.

Where is the study run from?
La Vega Hospital (Spain).

When is the study starting and how long is it expected to run for?
January 2013 to December 2016.

Who is funding the study?
Universidad de Murcia (Spain).

Who is the main contact?
Prof Alfredo Moreno-Egea
moreno-egea@ono.com

Contact information

Prof Alfredo Moreno-Egea
Scientific

Avda Primo de Rivera 7, 5ºD
Murcia
30008
Spain

Phone + 34(0) 639 66 21 13
Email moreno-egea@ono.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titlePrevention of the trocar-site hernia with prophylactic mesh: a randomized clinical trial
Study objectivesThe trocar-site hernia is a new complication in laparoscopic surgery which is becoming increasingly prevalent. Thus, the search for an efficient method of prophylaxis should be prioritized.

The aim of this study is to find out whether it is possible to prevent trocar-site hernia (umbilical site) after laparoscopic cholecystectomy using a prophylactic mesh.
Ethics approval(s)Hospital General Universitario Morales Meseguer Ethics Committee, 01/01/2013
Health condition(s) or problem(s) studiedTrocar-site hernia
InterventionPatients were randomized on the day of surgery to receive either a prophylactic mesh in the umbilical trocar site (treatment group) or no treatment in the umbilical site (no treatment - control group).
Intervention typeProcedure/Surgery
Primary outcome measureRecurrence rate at 1 year
Secondary outcome measures1. Operative time
2. Morbidity (infection, seroma or chronic pain) at 1 month and 3 months
Overall study start date01/01/2013
Completion date30/12/2016

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants100 patients: two groups of 50 patients
Key inclusion criteria1. Patients undergoing surgery for symptomatic cholelitiasis
2. Age range 20-70 years
3. Male and female
4. American Society of Anesthesiology (ASA) classification of 3 or less
5. No co-morbidity cardiopulmonary, hepatic or renal impairment
6. Consent was given for surgery
Key exclusion criteria1. Patients with ASA higher than 3
2. Current malignant diseases
3. Proven mental illness or other circumstances that might compromise the patient’s cooperation in addition to those who refused to give informed consent
Date of first enrolment01/01/2015
Date of final enrolment30/12/2016

Locations

Countries of recruitment

  • Spain

Study participating centre

La Vega Hospital
Murcia
30008
Spain

Sponsor information

Medical Cañada (Spain)
Industry

Calle Jubilo, S/N - Parcela 24 Nave C6
Poligono Industrial Oeste
San Ginés
Murcia
30820
Spain

Website www.medicalcanada.es
ROR logo "ROR" https://ror.org/011xgdn77

Funders

Funder type

University/education

Universidad de Murcia
Government organisation / Local government
Alternative name(s)
University of Murcia
Location
Spain

Results and Publications

Intention to publish date30/06/2016
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planTo be confirmed at a later date
IPD sharing plan